Tiadenol
Chemical compound
- C10AX03 (WHO)
- 2,2'-[decane-1,10-diylbis(thio)]diethanol
- 6964-20-1
- 23403
- 21885 Y
- 22251270CX
- D07191 Y
- DTXSID50219903
- Interactive image
- OCCSCCCCCCCCCCSCCO
InChI
- InChI=1S/C14H30O2S2/c15-9-13-17-11-7-5-3-1-2-4-6-8-12-18-14-10-16/h15-16H,1-14H2 Y
- Key:WRCITXQNXAIKLR-UHFFFAOYSA-N Y
Tiadenol is a hypolipidemic agent.[1]
References
- ^ Potì R, Quintavalla R, Manotti C (1977). "[Clinical experimentation with a new drug lowering blood lipids (Tiadenol)]". Giornale di Clinica Medica (in Italian). 58 (7–8): 293–300. PMID 336442.
- v
- t
- e
Lipid-lowering agents (C10)
Cholesterol absorption inhibitors, NPC1L1 |
|
---|---|
Bile acid sequestrants/resins (LDL) |
Statins (HMG-CoA reductase, LDL) | |
---|---|
Niacin and derivatives (HDL and LDL) | |
MTTP inhibitors (VLDL) | |
ATP citrate lyase inhibitors (LDL) | |
Thyromimetics (VLDL) |
PPAR agonists (LDL) |
| ||||
---|---|---|---|---|---|
CETP inhibitors (HDL) | |||||
PCSK9 inhibitors (LDL) | |||||
ANGPTL3 inhibitors (LDL/HDL) |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e